Published in Ned Tijdschr Geneeskd on September 15, 2007
[Amyloidosis and its treatment by eliminating the precursor protein]. Ned Tijdschr Geneeskd (2008) 0.75
[Mucocutaneous manifestations of amyloidosis]. Ned Tijdschr Geneeskd (2007) 1.35
[Two patients with a rare manifestation of amyloidosis in the respiratory system]. Ned Tijdschr Geneeskd (2007) 1.32
Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther (2010) 3.42
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Sentinel node detection in patients with breast cancer: low-energy all-purpose collimator or medium-energy collimator? Clin Nucl Med (2004) 1.47
Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med (2004) 1.43
Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses. J Thromb Haemost (2007) 1.42
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis. Amyloid (2001) 1.38
Therapeutic options in systemic AL amyloidosis. Neth J Med (2004) 1.12
[Efficient and improved diagnosis of osteoporosis by simultaneous bone density measurement and spinal morphometry]. Ned Tijdschr Geneeskd (2008) 1.12
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer (2005) 1.12
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls. Eur J Nucl Med Mol Imaging (2008) 1.08
Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging (2009) 1.04
Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Endoscopy (2008) 1.00
Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT. J Nucl Cardiol (2014) 0.97
Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol (2004) 0.96
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum (2009) 0.94
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin. Eur J Endocrinol (2003) 0.92
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. Br J Surg (2006) 0.91
Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis (2002) 0.90
Limited additional value of positron emission tomography in staging oesophageal cancer. Br J Surg (2007) 0.89
Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol (2004) 0.89
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eur J Nucl Med Mol Imaging (2005) 0.88
PET-CT: a matter of opinion? Eur J Nucl Med Mol Imaging (2003) 0.85
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour. Ann Oncol (2009) 0.84
Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol (2004) 0.82
Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability. Nucl Med Commun (2003) 0.82
Clinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener's granulomatosis. Ann Rheum Dis (2003) 0.82
Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma. Clin Endocrinol (Oxf) (2000) 0.82
Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies. Br J Pharmacol (2012) 0.81
Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot study. Eur J Surg Oncol (2005) 0.80
Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. Eur Heart J (2002) 0.80
Zero coronary calcium in the presence of three-vessel and left main coronary artery disease in a Hodgkin lymphoma survivor. Neth Heart J (2015) 0.80
[Four patients with incidentalomas of the thyroid discovered on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET)]. Ned Tijdschr Geneeskd (2007) 0.79
Restenosis prevalence and long-term effects on renal function after percutaneous transluminal renal angioplasty. Nephron (1986) 0.77
Axillary recurrence after sentinel lymph node biopsy. Eur J Surg Oncol (2004) 0.77
Gated blood-pool SPECT automated versus manual left ventricular function calculations. Nucl Med Commun (2004) 0.76
4-Aminopyridine and haemodialysis in the treatment of verapamil intoxication. Hum Toxicol (1985) 0.76
Evaluation of right ventricular function by NuSMUGA software: gated blood-pool SPECT vs. first-pass radionuclide angiography. Int J Cardiovasc Imaging (2003) 0.76
Vertebral fracture prevalence in a referral population of 750 Canadian men and women. Clin Radiol (2012) 0.76
Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans. J Clin Endocrinol Metab (2000) 0.75
Nuclear cardiac imaging for the assessment of myocardial viability. Neth Heart J (2005) 0.75
[Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy]. Ned Tijdschr Geneeskd (2006) 0.75
[Treatment of patients with differentiated thyroid carcinoma]. Ned Tijdschr Geneeskd (2002) 0.75
[Clinical thinking and decision making in practice. A nurse with acute pain between shoulder blades]. Ned Tijdschr Geneeskd (2000) 0.75
[Three patients with massive pulmonary embolism]. Ned Tijdschr Geneeskd (2002) 0.75
[Results of percutaneous transluminal angioplasty in renal artery stenosis in 1978-1986]. Ned Tijdschr Geneeskd (1989) 0.75
New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma. Eur J Surg Oncol (2002) 0.75
Diagnostic performance of measuring free light chains in fat tissue of patients with AL amyloidosis. Amyloid (2011) 0.75
[Hybrid cardiac SPECT-CT proves safe and effective: diagnosis of coronary heart disease completed in one day]. Ned Tijdschr Geneeskd (2017) 0.75
Fatal rupture of a mycotic aneurysm of the right coronary artery post pneumococcal sepsis. Neth J Med (2017) 0.75
An automated synthesis module for preparation of L-3-[123I]iodo-alpha-methyl tyrosine. Appl Radiat Isot (2001) 0.75
[Value of the 'non-diagnostic' lung scan--further classification of pulmonary embolism not reliable]. Ned Tijdschr Geneeskd (2001) 0.75
[Flank pain caused by a renal artery dissection]. Ned Tijdschr Geneeskd (2017) 0.75
Thyroid cancer imaging. Cancer Treat Res (2004) 0.75
[Giant urinoma of the thigh]. Ned Tijdschr Geneeskd (1998) 0.75
Converting enzyme-induced reversible deterioration of renal function in a patient with unilateral renal artery stenosis. Clin Nephrol (1984) 0.75
[Acute acalculous cholecystitis: not only in the intensive care department]. Ned Tijdschr Geneeskd (2002) 0.75
Measurable regression of systemic light chain (AL) amyloid in fat tissue after a response of amyloidogenic free light chain in serum. Amyloid (2011) 0.75
[Treatment of renovascular hypertension: surgery or dilatation?]. Ned Tijdschr Geneeskd (1986) 0.75
Scintigraphic evaluation for tear drainage, after dacryocystorhino- stomy, in relation to patient satisfaction. Eye (Lond) (2006) 0.75